CROs dMed and Clinipace Merge To Accelerate Customer Success

dMed Global, a full-service Clinical Contract Research Organization (CRO) based in Shanghai, China, and UF startup Clinipace Incorporated, a full-service clinical CRO with headquarters in North Carolina, USA, announced that the two companies will merge.

Dialectic Therapeutics Receives FDA Clearance of IND Application for for Its Lead Product Candidate To Treat Cancer

UF startup Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and Drug Administration (FDA) has concluded that Dialectic may proceed with its clinical investigation for its lead product candidate, DT2216, a unique compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD) technology.